FOLFOXIRI Protocol Clinical Trials

2 actively recruiting trials

Also known as: Bevacizumab, Cetuximab, Panitumumab, modified FOLFIRINOX, modified FOLFOXIRI

Filter by location:

Other2 trials

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Phase 2

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.